305
Views
26
CrossRef citations to date
0
Altmetric
Special Focus: Vaccine Adjuvants - Review

Adjuvants containing natural and synthetic Toll-like receptor 4 ligands

&
Pages 793-807 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Steven G Reed. (2013) Vaccine adjuvants. Expert Review of Vaccines 12:7, pages 705-706.
Read now

Articles from other publishers (25)

Gang Hu, David J. Varisco, Sayan Das, C. Russell Middaugh, Francesca Gardner, Robert K. Ernst, Wendy L. Picking & William D. Picking. (2023) Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists. Heliyon 9:7, pages e18119.
Crossref
Xingyu Heng, Ruyan Feng, Lijuan Zhu, Liyin Yu, Gaojian Chen & Hong Chen. (2022) Dendritic cells maturation facilitated by group-adjustable lipopolysaccharide analogues synthesized via RAFT polymerization. Chinese Chemical Letters 33:9, pages 4331-4334.
Crossref
Yazdan Mokhtari, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, Nader Bagheri, Seyed H. Ghaffari & Davood Bashash. (2020) Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis. Journal of Cellular and Molecular Medicine 25:2, pages 639-651.
Crossref
Leopoldo Fabrício Marçal do Nascimento, Luana Dias de Moura, André Luis Souza dos Santos, Aarthy C Vallur & Maria do Socorro Pires e Cruz. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases 29 46 .
Caitlín Ní Chasaide & Kingston H.G. Mills. (2020) Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract. Vaccines 8:4, pages 621.
Crossref
Youri Lee, Eun-Ju Ko, Ki-Hye Kim, Young-Tae Lee, Hye Suk Hwang, Yu-Jin Jung, Subbiah Jeeva, Young-Man Kwon, Baik Lin Seong & Sang Moo Kang. (2019) The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants. Antiviral Research 168, pages 100-108.
Crossref
Leopoldo Fabrício Marçal do Nascimento, Luana Dias de Moura, Rebecca Tavares Lima & Maria do Socorro Pires e Cruz. (2019) Novos adjuvantes vacinais: importante ferramenta para imunoterapia da leishmaniose visceral. HU Revista 44:3, pages 401-410.
Crossref
Jo-Yu Hong, Ting-Hsuan Chen, Yu-Jou Chen, Chia-Chyi Liu, Jia-Tsrong Jan & Suh-Chin Wu. (2019) Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development. Antiviral Research 164, pages 12-22.
Crossref
Susan L. Baldwin, Sasha E. Larsen, Diane Ordway, Gail Cassell & Rhea N. Coler. (2019) The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases. PLOS Neglected Tropical Diseases 13:2, pages e0007083.
Crossref
Anshika Tandon, Manisha Pathak, Munesh Kumar Harioudh, Sabahuddin Ahmad, Mohd Sayeed, Tayyaba Afshan, M.I. Siddiqi, Kalyan Mitra, Shailja M. Bhattacharya & Jimut Kanti Ghosh. (2018) A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice. Journal of Biological Chemistry 293:51, pages 19874-19885.
Crossref
Michele Catanzaro, Emanuela Corsini, Michela Rosini, Marco Racchi & Cristina Lanni. (2018) Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea. Molecules 23:11, pages 2778.
Crossref
Neal Van Hoeven, Steven Wiley, Emily Gage, Andrew Fiore-Gartland, Brian Granger, Sean Gray, Christopher Fox, David E. Clements, D. Elliot Parks, Scott Winram, Dan T. Stinchcomb, Steven G. Reed & Rhea N. Coler. (2018) A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen. npj Vaccines 3:1.
Crossref
Eun-Ju Ko, Youri Lee, Young-Tae Lee, Yu-Jin Kim, Ki-Hye Kim & Sang-Moo Kang. (2018) MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine. Antiviral Research 156, pages 107-115.
Crossref
C.B. Fox, D. Carter, R.M. Kramer, A.M. Beckmann & S.G. Reed. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines 105 127 .
Jason D. Marshall, Darren S. Heeke, Eileen Rao, Sean K. Maynard, David Hornigold, Christopher McCrae, Neil Fraser, Andrey Tovchigrechko, Li Yu, Nicola Williams, Sarah King, Martin E. Cooper, Adeline M. Hajjar & Jennifer C. Woo. (2016) A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation. PLOS ONE 11:10, pages e0164632.
Crossref
Luxi Chen & Jianhua Yu. (2016) Modulation of Toll-like receptor signaling in innate immunity by natural products. International Immunopharmacology 37, pages 65-70.
Crossref
Neal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, Angela Bosco-Lauth, Christopher Fox, Richard A. Bowen, David E. Clements, Timothy Martyak, D. Elliot Parks, Susan Baldwin, Steven G. Reed & Rhea N. Coler. (2016) A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. PLOS ONE 11:2, pages e0149610.
Crossref
Jean Haensler, Patricia Probeck, Jin Su, Fabienne Piras, François Dalençon, Jean-François Cotte, Véronique Chambon, Shehzad M. Iqbal, Lynn Hawkins & Nicolas Burdin. (2015) Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion. International Journal of Pharmaceutics 486:1-2, pages 99-111.
Crossref
Jingjing Guo, Yi Yang, Wenjun Xiao, Weilai Sun, Hong Yu, Lanying Du, Sara Lustigman, Shibo Jiang, Zhihua Kou & Yusen Zhou. (2015) A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein. Vaccine 33:16, pages 1974-1980.
Crossref
Jolanda Brummelman, Kina Helm, Hendrik-Jan Hamstra, Peter van der Ley, Claire J.P. Boog, Wanda G.H. Han & Cécile A.C.M. van Els. (2015) Modulation of the CD4+ T cell response after acellular pertussis vaccination in the presence of TLR4 ligation. Vaccine 33:12, pages 1483-1491.
Crossref
Giuseppe Del Giudice, Birgit Weinberger & Beatrix Grubeck-Loebenstein. (2015) Vaccines for the Elderly. Gerontology 61:3, pages 203-210.
Crossref
Keith D. Miller, Richard Roque & Christopher H. Clegg. (2014) Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier. PLoS ONE 9:12, pages e114366.
Crossref
Joshua O. Sestak, Amir Fakhari, Ahmed H. Badawi, Teruna J. Siahaan & Cory Berkland. (2014) Structure, Size, and Solubility of Antigen Arrays Determines Efficacy in Experimental Autoimmune Encephalomyelitis. The AAPS Journal 16:6, pages 1185-1193.
Crossref
Céline Vaure & Yuanqing Liu. (2014) A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species. Frontiers in Immunology 5.
Crossref
Weidong Zhang, Gul Ahmad, Loc Le, Juan U. Rojo, Souvik Karmakar, Kory A. Tillery, Workineh Torben, Raymond T. Damian, Roman F. Wolf, Gary L. White, David W. Carey, Darrick Carter, Steven G. Reed & Afzal A. Siddiqui. (2014) Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon. Parasitology Research 113:6, pages 2239-2250.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.